The QualityStocks Daily Stock List
- Body and Mind, Inc. (BMMJ)
- International Spirits & Wellness Holdings, Inc. (ISBG)
- Flux Power Holdings, Inc (FLUX)
- Great Bear Resources Ltd. (GTBDF)
- Innovus Pharmaceuticals, Inc. (INNV)
- Quanta, Inc. (QNTA)
- WeedMD, Inc. (WDDMF)
- BioCardia, Inc. (BCDA)
- Anvia Holdings Corporation (ANVV)
- Geospatial Corp. (GSPH)
- Real Goods Solar, Inc. (RGSE)
- First Foods Group, Inc. (FIFG)
- Zenosense, Inc. (ZENO)
- Grow Solutions Holdings, Inc. (GRSO)
Body and Mind, Inc. (BMMJ)
Penny Stock Tweets, New Cannabis Ventures, Midas Letter, Dividend Investor, Wallmine, Market News Updates, PotStockNews, Investor Ideas, Stockhouse, MicroSmallCap, Wallet Investor, GuruFocus, Trading View, Simply Wall St, InvestorsHub, and Insider Financial reported earlier on Body and Mind, Inc. (BMMJ), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Body and Mind, Inc. invests in high quality medical and recreational cannabis cultivation, production and retail. The Company’s wholly-owned Nevada subsidiary was awarded one of the first medical marijuana cultivation licences. Additionally, Body and Mind holds cultivation and production licenses. Body and Mind (BaM) products include dried flower, edibles, topicals, extracts, and GPEN Gio cartridges. Body and Mind is headquartered in Vancouver, British Columbia. Nevada Medical Group LLC (NMG Nevada) is a wholly-owned subsidiary of Body and Mind.
Body and Mind has collected, for many years’, elite cannabis plants from around the world. Through carefully crossbreeding these plants, it has developed strains that give what it states are the perfect balance of body and mind benefits. Its cannabis plants are grown with hands-on care in small batches. Furthermore, Body and Mind never uses synthetic pesticides. The Company offers an array of strains, available in flower, vapes, pre-rolls and concentrates.
Body and Mind announced in March 2019 expansion into Arkansas with in-State partner, Comprehensive Care Group LLC (CCG). The companies will work together to develop a medical marijuana dispensary facility in West Memphis, Arkansas. Medical marijuana dispensaries in Arkansas are licensed for retail sales and cultivation of up to 50 plants within the same facility.
Body and Mind signed a long term lease to relocate its production facility to a new campus within one mile of the Pepper Lane cultivation facility. The new facility is roughly 7,500 square feet. Body and Mind’s plan is to move the current production licence. It will not need to apply for a new license to produce edibles, oils and extracts.
Body and Mind has started manufacturing in California by way of the Body and Mind California subsidiary NMG Cathedral City (NMG). The Cathedral City facility has been producing THC (Tetrahydrocannabinol) distillate in bulk form since June 2018. The facility is planned to be outfitted to manufacture popular Body and Mind products. This includes oils, wax, live resin, ambrosia, as well as edibles.
Last week, Body and Mind provided an update on the ShowGrow dispensaries in Long Beach and San Diego, California.
Mr. Robert Hasman, President of Nevada Medical Group, LLC and Board member of Body and Mind, said, "We are pleased to move one step closer towards the closing of the transaction for ShowGrow Long Beach, which is currently operational and cash flow positive, and the closing of the transaction for ShowGrow San Diego, presently under construction and expected to open in the near term. California is a key part of our growth strategy and falls in line with our plan to invest in profitable, undervalued assets, in limited license jurisdictions. We look forward to working with the ShowGrow team and closing the transaction during the second half of this year."
Body and Mind, Inc. (BMMJ), closed Wednesday's trading session at $0.68761, off by 5.2095%, on 229,369 volume with 106 trades. The average volume for the last 3 months is 195,975 and the stock's 52-week low/high is $0.25999999/$2.70000004.
International Spirits & Wellness Holdings, Inc. (ISBG)
Undergroundstocks, Market Screener, Investor Ideas, Investor News, Financial Buzz, Spotlight Growth, OTC Markets, Stock News Feed, NewMediaWire, and Insider Tracking reported previously on International Spirits & Wellness Holdings, Inc. (ISBG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
International Spirits & Wellness Holdings, Inc. (ISBG) is a top-tier brand incubator in the Global Wine & Spirits and CBD-Infused Products markets. It is an authorized importer, licensor, and marketer of premium beverage brands, with sales of innovative products and brands around the world. The Company previously went by the name International Spirits & Beverage Group, Inc. It changed its name to International Spirits & Wellness Holdings, Inc. this month. The Company is based in Nevada.
ISBG develops and grows brands through all phases. This includes concept creation, product development, market positioning, sales and marketing. The Company’s goal is to be a worldwide innovation leader within the alcohol beverage and cannabis industries. It will source early stage brands, existing brands with unrealized potential, and create in-house brands that raises innovation and expectations with trade and consumer. In addition, ISBG has partnered with Bengala Technologies to develop and commercialize enterprise and B2B software technology products targeting the logistics and supply-chain marketplace.
ISBG’s latest brand is P19. It is the Company’s first entrance into the explosive CBD (cannabidiol) space. It partnered with best-in-class CBD experts at BioPulse Labs. P19 was created around developing the finest CBD products such as gummies, topicals, tinctures, and more.
At present, the Company’s Wine and Spirit portfolio is led by Besado Tequila. This is ISBG’s innovative entrance within the growing ultra-premium tequila segment. Moreover, the Company’s Dziaq (dee-zee-ack) Liqueur re-brand to a wine based ready-to-serve cocktail line allows for significantly greater distribution channels (2 x spirit based alternatives).
Last week, ISBG announced that it was forced to move to restock inventories of popular CBD-based products ahead of schedule because of unforeseen levels of demand.
ISBG Chief Executive Officer, Terry Williams, said, “We have seen a market response for our P19 CBD products that goes well beyond our expectations. The whole spectrum of products has outperformed. We chalk this up to two main factors: better-than-expected macro market dynamics – specifically the big jump in overall CBD demand in 2019 toward a pace of $5 billion in CBD-product sales – as well as strong results from our product-specific branding process. In other words, we have executed well in a favorable context.”
International Spirits & Wellness Holdings, Inc. (ISBG), closed Wednesday's trading session at $0.0009, even for the day, on 15,299,188 volume with 29 trades. The average volume for the last 3 months is 20,095,873 and the stock's 52-week low/high is $0.00078/$0.039999999.
Flux Power Holdings, Inc. (FLUX)
NetworkNewsWire, Zacks, Alt Energy Stocks, Whale Wisdom, OTC Markets, StreetWise Reports, Research Pool, Proactive Investors, Equity Clock, Market Exclusive, Market Screener, InvestorsHub, Stockhouse, and Wallet Investor reported previously on Flux Power Holdings, Inc. (FLUX), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Flux Power Holdings, Inc., via its subsidiary Flux Power, Inc., designs, develops, and sells rechargeable lithium-ion energy storage systems for industrial applications in the United States. Its focus is Advanced Lithium-ion Battery Technology. Flux was established in 2009 and it first concentrated on electric automobiles. It turned to industrial equipment in 2013. OTCQB-listed, Flux Power Holdings is based in Vista, California.
The Company is the only lithium provider with a UL Listing for multiple original equipment manufacturers (OEM’s). Flux’s products include its Class 3 Walkie LiFT Pack that was introduced in 2014. It is the only pack tested and approved by major OEM’s: Toyota, Raymond, and Crown Equipment. Flux achieved UL approval in 2016 and is the only UL Listed pack in the forklift industry for multiple forklift brands.
Flux Power’s products include battery cell management system (BMS) that provides cell balancing, monitoring, and error reporting functions for battery systems. In addition, the Company’s products include energy storage modules for industrial equipment, electrical vehicles, as well as governmental applications.
Flux also offers 24-volt onboard chargers and smart wall mounted chargers to interface with its BMS; and integrates lithium packs in varied applications. This includes forklifts and related industrial equipment. Moreover, the Company develops a set of complementary technologies and products for its BMS products. Its products are used in airport ground support equipment.
Earlier this month, Flux Power Holdings announced preliminary results for its Fiscal 2019 Q4 and year ended June 30, 2019. The Company expects to report final Fiscal 2019 Q4 and year-end results in September 2019.
Flux Power announced that it expects Q4 ’19 Net Revenue of roughly $3.0 million. This represents an increase of more than 170 percent versus Q4 ’18 Net Revenue of $1.1 million and a new quarterly record.
The Company expects its Fiscal 2019 Net Revenue to increase by at least 115 percent to roughly $9.0 million, versus $4.1 million for FY 2018. Flux Power expects to report positive Gross Profit Margins for Q4’19 and its full Fiscal 2019 year, versus negative Gross Profit Margins in the respective FY 2018 periods.
Flux Power Holdings, Inc. (FLUX), closed Wednesday's trading session at $0.90, off by 28.00&, on 1,743 volume. The average volume for the last 3 months is 517 and the stock's 52-week low/high is $0.90/$31.50.
Great Bear Resources Ltd. (GTBDF)
Street Insider, Streetwise Reports, Stockhouse, Investing News, Metals News, Connecting Investor, Stockwatch, Mining Capital, Junior Mining Network, and Wallet Investor reported earlier on Great Bear Resources Ltd. (GTBDF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Great Bear Resources Ltd. engages in the acquisition and exploration of mineral properties in Canada. It holds interests in the Dixie property, which is located about 15 minutes' drive along Highway 105 from downtown Red Lake, Ontario. The Red Lake mining district has produced more than 30,000,000 ounces of gold. It is one of the premier mining districts in Canada. Incorporated in 2001, Great Bear Resources is based in Vancouver, British Columbia.
The Dixie property encompasses a drill and geophysically defined 10 kilometer gold mineralized structure similar to that hosting other producing gold mines in the district. At the Dixie Project, gold mineralization is confirmed along a 2.3 km strike of a 10 km target. The system at Dixie has a high-grade gold zone, which includes recent intervals of 16.35 meters of 26.91 g/t gold and 7.00 meters of 68.76 g/t gold and is open along strike and at depth.
In addition, Great Bear Resources is earning a 100 percent royalty-free interest in the West Madsen, Pakwash, Dedee and Sobel properties. These cover regionally significant gold-controlling structures and prospective geology. The West Madsen project consists of two claims blocks, the easternmost (Block A) is now directly contiguous to Pure Gold Mining’s Madsen property. Each block is roughly six kilometers by three kilometers in size, for a total area of 3,860 hectares.
Great Bear Resources earlier reported the discovery of a new gold control within its Dixie Limb Zone (DL) target associated with thickened and higher-grade gold mineralization. The new discovery enhances the DL as a significant potential host of high-grade gold. The DL is the original gold discovery at the Dixie project, made by Teck Resources. It is around 200 meters to the north of, and is sub-parallel to, Great Bear's 2018 high-grade gold discovery at the Hinge Zone (DHZ).
Last month, Great Bear Resources announced that it entered into an agreement with Cormark Securities, Inc. to act as lead underwriter of a syndicate of underwriters that includes Canaccord Genuity Corp. The Underwriters shall purchase 1,000,000 common shares that qualify as "flow-through shares" of the Company for the purposes of the Income Tax Act (Canada) (Flow-Through Common Shares) at a price of $5 .45 per Flow-Through Common Share, on a "bought deal" private placement basis, for aggregate gross proceeds to the Company of approximately C$5 .45 million.
Great Bear Resources has also granted the Underwriters an option to sell up to an additional 150,000 Flow-Through Common Shares at the offering price up to the Closing Date. The proceeds from this Offering will be used to incur "Canadian exploration expenses" (within the meaning of the Income Tax Act ( Canada )) related to Great Bear's projects in the Province Ontario. The Company will renounce these expenses to the purchasers with an effective date of no later than December 31, 2019.
Great Bear Resources Ltd. (GTBDF), closed Wednesday's trading session at $3.95, off by 4.8078%, on 35,636 volume with 68 trades. The average volume for the last 3 months is 35,698 and the stock's 52-week low/high is $0.393476009/$4.30999994.
Innovus Pharmaceuticals, Inc. (INNV)
NetworkNewsWire, Zacks, Street Insider, Micro Cap Daily, Stockwatch, StreetWise Reports, Marketbeat, OTC Markets, Stockaholics, Insider Financial, GlobeNewswire, Simply Wall St, 4-Traders, and Stockhouse reported beforehand on Innovus Pharmaceuticals, Inc. (INNV), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Innovus Pharmaceuticals, Inc. is an emerging commercial-stage pharmaceutical company based in San Diego, California. The Company delivers safe, innovative and effective over-the-counter (OTC) medicine and consumer care products to improve men’s and women's health and respiratory diseases. Its dedication is to being a leader in developing and marketing new OTC and branded Abbreviated New Drug Application (ANDA) products. Established in 2008, Innovus Pharmaceuticals lists on the OTCQB.
The Company is pursuing opportunities where existing prescription drugs have recently, or are expected to, change from prescription (Rx) to OTC. Innovus delivers unique and innovatively presented and packaged health solutions via its OTC medicines and consumer and health products that it markets directly, via commercial partners to primary care physicians, urologists, gynecologists and therapists, and directly to consumers via its on-line channels, retailers and wholesalers.
Innovus Pharmaceuticals has products for a range of indications. These include Brain Health, Diabetes, Fertility, Men’s Health, Pain Management, Respiratory, Vitality, Vision, and Women’s Health.
Last month, Innovus Pharmaceuticals announced that it has made major progress on the regulatory and manufacturing steps required to obtain market authorization from Health Canada to commercialize its FlutiCare® brand in Canada. It expects to secure the needed market authorization, manufacturing and supply of the product from an existing Canadian manufacturer during the second half of 2019 pending Health Canada approval. The product is expected to be available as an OTC in that country and will not require a prescription.
In addition to FlutiCare®, Innovus recently jointly announced with its former distribution partner, Acerus Pharmaceuticals, Inc., that it would be receiving back all the rights to its product UriVarx®, approved for the relief of symptoms of overactive bladder and urine incontinency, by Health Canada. Innovus Pharmaceuticals has 13 products approved and commercialized in Canada. These include Zestra®, Zestra Glide®, Uxor®, DiabaSens®, Vesele®, RecalMax®, UriVarx®, ProstaGorx®, BH Testosterone®, AllerVarx®, Xyralid® Cream, Xyralid® Suppositories, and Apeaz®. The Company has filed or is in the process of filing for six additional products including, FlutiCare®, PeVarx®, Healthifeet®, Breastlift®, ArthriVarx® and CarvaNum™.
Last week, Innovus Pharmaceuticals announced that its Delta Prime Savings Club™ E-commerce marketplace (DPSC) is on course for annual sales of roughly $3 million. The DPSC, one of Innovus’ primary E-Commerce marketplaces, was purchased by the Company in early 2019 for approximately $35,000 plus approximately $300,000 in inventory. It specializes in selling numerous kinds of consumer products in addition to Innovus’ OTC ANDA and supplement products and other general consumer care products.
Innovus Pharmaceuticals, Inc. (INNV), closed Wednesday's trading session at $1.43, off by 6.5359%, on 2,954 volume with 13 trades. The average volume for the last 3 months is 4,025 and the stock's 52-week low/high is $1.25/$18.375.
Quanta, Inc. (QNTA)
Zacks, Investor Ideas, Market Screener, Stockopedia, Last10k, TradingView, BioSpace, and Simply Wall St reported earlier on Quanta, Inc. (QNTA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Quanta, Inc. is an applied science company centered on enhancing energy levels in plant matter, including hemp and cannabis, to increase performance within the human body. The Company’s proprietary technology uses quantum mechanics to increase bioactivity of targeted molecules to enhance the desired effects. Quanta specializes in potentiating rare, naturally occurring elements to create impactful and sustainable healing solutions that are as powerful and predictable as pharmaceutical drugs. The Company lists on the OTC Markets. Quanta has its corporate office in Los Angeles, California.
Quanta offers its technology as a platform to product makers via distribution channels and consumer products. It serves brands in cannabis, anti-aging, health and wellness, stress management, pain management, fitness and brain performance enhancement.
The Company’s CBD (cannabidiol) pain relief rub is an all-natural CBD topical that consists of 13 natural elements. These include turmeric, arnica and polarized CBD. The design is to provide relief from pain, inflammation, as well as stiffness in muscles and joints.
Last month, Quanta announced that it has partnered with Kapno to sell the Company's CBD Muscle Rub and CBD Vape. Kapno distributes brands online by way its existing global network. Kapno has 2.4 billion followers across all social platforms.
Today, Quanta announced that it has partnered with PharmaLynk. PharmaLynk is known for their distribution of innovative and effective health products through their existing network to more than 1000 independent pharmacies across the nation. This partnership with Quanta allows for the immediate sale of Quanta's CBD Muscle Rub and CBD Vape products in greater than 100 independent pharmacies nationwide, before expanding to their remainder pharmacies over the coming year.
The majority of these pharmacies will be in California. However, pharmacies from Alaska to Florida will be introduced and will begin selling Quanta with PharmaLynk's assistance. PharmaLynk helps independent pharmacies to expand business with existing customers. It provides strategies to attract new customers and creates opportunities for new revenue streams.
Quanta, Inc. (QNTA), closed Wednesday's trading session at $2.15, up 13.1579%, on 200 volume with 2 trades. The average volume for the last 3 months is 30 and the stock's 52-week low/high is $1.00/$5.00.
WeedMD, Inc. (WDDMF)
Daily Marijuana Observer, Stock Day Media, OTC Markets, CannabisMarketCap, Pot Stock News, Micro Small Cap, Financial Insiders, Marijuana Stock Review, Profit Confidential, The Cannabis Investor, Investor Ideas, New Cannabis Ventures, Financial Buzz, Micro Small Cap, Midas Letter, Morningstar, and Stockwatch reported previously on WeedMD, Inc. (WDDMF), and we also report on the Company, here at the QualityStocks Daily Newsletter.
WeedMD, Inc. is a federally-licensed producer and distributor of medical-grade cannabis. It is the publicly-traded parent company of WeedMD Rx, Inc., which is a federally-licensed producer and distributor of cannabis products for the medical and adult-use markets. WeedMD has a multi-channeled distribution strategy. This includes selling directly to medical patients, strategic relationships across the seniors’ market, and supply agreements with Shoppers Drug Mart and also six provincial distribution agencies. OTCQX-listed, WeedMD is based in Aylmer, Ontario.
WeedMD owns and operates two facilities. One is a 26,000 sq. ft. facility in Aylmer, Ontario. The other is a 158-acre state-of-the-art greenhouse and outdoor facility in Strathroy, Ontario. Currently, the Company has 136,000 square feet of licensed indoor and greenhouse production space across its facilities.
The expectation is that WeedMD will have a total footprint of greater than 550,000 square feet of indoor and greenhouse production space online this year. Additionally, 27 acres of outdoor cultivation has been approved for cultivation. First harvest is expected this autumn. The Aylmer facility currently produces premium indoor flower.
WeedMD recently announced the launch of Color™ Cannabis. Color Cannabis was developed specifically for a varied adult-use market that reflects the range in tastes and preferences of modern cannabis consumers. Color Cannabis products include an array of strains, in numerous formats, developed with premier quality cannabis. Color Cannabis is a first-rate brand exclusively available to distributors and select retailers throughout Canada.
Along with premium dried flower, Color Cannabis will launch new product formats in the coming months. These include pre-rolls, oils, and gel capsules with further consumption formats in development. Color will offer up to 10 unique strains from WeedMD’s proprietary genetics collection. This collection includes several signature strains - Pedro’s Sweet Sativa, Ghost Train Haze, White Shark, ACDC, Ultra Sour and Mango Haze.
Last week, WeedMD announced it launched CX Industries, Inc., a wholly-owned subsidiary. CX Industries will specialize in extraction, toll processing and third-party product formulation from WeedMD’s fully-licensed Aylmer, Ontario facility. CX Industries will have the capacity to process greater than 200,000 kgs of biomass at its peak production in 2020.
In addition, last week, WeedMD, subsidiary CX Industries, and Ignite International Brands, Ltd. announced they entered into an exclusive licensing agreement for an initial term of two years with an option for a third year. The Ignite brand is established around the world and recognized for its premium suite of cannabis and CBD products. The initial product launch will include an assortment of THC and CBD products for the Canadian market.
WeedMD, Inc. (WDDMF), closed Wednesday's trading session at $1.1701, up 3.5487%, on 95,640 volume with 118 trades. The average volume for the last 3 months is 89,463 and the stock's 52-week low/high is $0.728299975/$1.95000004.
BioCardia, Inc. (BCDA)
StockTwits, Zacks, Insider Tracking, Street Insider, Stockopedia, Marketbeat, Capital Cube, Wallet Investor, AI Stock Finder, Dividend Investor, Barchart, and Stockhouse reported previously on BioCardia, Inc. (BCDA), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
BioCardia, Inc. is a leader in the development of comprehensive solutions for cardiovascular regenerative therapies. The Company’s biotherapeutic product candidates in clinical development are CardiAMP and CardiALLO cell therapies. A clinical-stage regenerative medicine company, BioCardia has its corporate headquarters in San Carlos, California. The Company’s shares trade on the OTC Markets Group’s OTCQB.
BioCardia also offers the Helix biotherapeutic delivery system; and the Morph vascular access product line, which provides catheter products. The Company’s lead therapeutic candidate is the investigational CardiAMP™ Cell Therapy System. It provides an autologous bone marrow derived cell therapy (using a patient's own cells) for the treatment of two clinical indications. These are heart failure that develops after a heart attack and chronic myocardial ischemia.
BioCardia’s second therapeutic candidate is the investigational CardiALLO™ Cell Therapy System. This is an allogeneic culture expanded "off the shelf" cell therapy derived from donor bone marrow cells, which have been identified to meet specified criteria. The therapy has the potential to be advanced for numerous clinical indications. This includes heart failure.
Earlier in May, BioCardia announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the AVANCE™ steerable introducer product family, designed for introducing different cardiovascular catheters into the heart. This includes through the left side of the heart via the interatrial septum.
The AVANCE steerable introducer family takes advantage of Morph “DNA” technology. This is an enhancement of BioCardia’s FDA-cleared Morph steerable introducer that adds a number of features that make the devices ideal for use in transseptal procedures and are designed to improve upon commercially-available offerings.
BioCardia also partners with other biotherapeutic companies. This is to provide its Helix systems and clinical support to their programs studying therapies for the treatment of heart failure, chronic myocardial ischemia, as well as acute myocardial infarction.
Last week, BioCardia announced positive results from a study of its Helix™ Biotherapeutic Delivery System for cell therapy used to treat patients early following acute myocardial infarction (AMI) to prevent long term heart failure. The results were presented on May 23, 2019 at EuroPCR by Christina Paitazoglou, MD, with the Cardiologicum Hamburg, Germany during a Hot Line/Late Breaking Trials session of inventive first-in-man trials and early phase studies entitled “Early transendocardial injection of autologous bone marrow-derived mononuclear cells following ischaemic myocardial events: the Alster-Helix registry.”
Dr. Paitazoglou in her presentation said, “Results suggest that intramyocardial cell therapy possibly improves left ventricular function and symptoms by attenuating myocardial remodeling on top of successful PCI and optimal standard care after AMI. Results (for the Helix™ system) are similar to the NOGA-treated patients, as previously observed in the ALSTER stem cell trial.”
BioCardia, Inc. (BCDA), closed Wednesday's trading session at $17.00, up 41.6667%, on 6,097 volume with 25 trades. The average volume for the last 3 months is 570 and the stock's 52-week low/high is $7.30000019/$17.50.
Anvia Holdings Corporation (ANVV)
Stock Target Advisor, GlobeNewswire, MarketWatch, Barchart, Simply Wall St, GuruFocus, Stockhouse, Trading View, Market Screener, Last10k, Stockwatch, Wallet Investor, Dividend Investor, and InvestorsHub reported beforehand on Anvia Holdings Corporation (ANVV), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, Anvia Holdings Corporation is an international technology for self and business improvement company. It has acquired and developed a number of proprietary software, mobile applications, learning and educational tools to help consumers and businesses improve and grow. The Company’s mission is to make personal and business growth accessible and sustainable.
The Company was previously known as Dove Street Acquisition Corporation. It changed its name to Anvia Holdings Corporation in January of 2017. Founded in 2016, Anvia Holdings is headquartered in Glendale, California.
The Anvia business and organizational portfolio comprises software and mobile application technologies, consulting services, coaching services, and blended learning content and activities. Some of the areas it serves its business clients are Strategy Management, Competency Management, Performance Management, Learning Management, Customer Experience Management, Franchise, Corporate Advisory and Listing, and HR Information Systems.
Last week, Anvia Holdings announced that it executed a definitive agreement to acquire all of the issued and outstanding shares of XSEED Pty Ltd, an Australian Registered Training Organization. With this agreement, Anvia Holdings, via its fully-owned subsidiary Anvia (Australia) Pty Ltd shall acquire 100 percent of XSEED Pty Ltd outstanding shares for approximately USD 352,000 (AUD 500,000). XSEED engages in the provision of vocational education training (VET) and offers courses that are for the Automotive and Hairdressing industries.
Anvia (Australia) Pty Ltd Chief Executive Officer, Mr. James Kennett, said “Adding XSEED to our education services portfolio solidifies our position in Australia as a major player in Education Services. In addition, XSEED will diversify our current CRICOS and Corporate learning income with further revenue sources.”
Moreover, last week, Anvia Holdings announced it filed an application to list its common shares on the NASDAQ Capital Market. Ali Kasa, Chief Executive Officer and President of Anvia Holdings, said, “The listing of our common shares on NASDAQ would reflect the progress we are making to strengthening our corporate governance and mark another significant milestone in our quest to become a global leader in the self and business improvement industry.”
Anvia Holdings Corporation (ANVV), closed Wednesday's trading session at $0.44, up 109.5238%, on 400 volume with 2 trades. The average volume for the last 3 months is 34,237 and the stock's 52-week low/high is $0.50999999/$6.00.
Geospatial Corp. (GSPH)
Penny Sleuth, Micro Cap Research, InvestorsHub, Market Screener, 4-Traders, Morningstar, MarketWatch, PR Newswire, GuruFocus, HotStockChat, YCharts, Wallet Investor, SmallCapVoice, Trading View, The Street, last10k, and Simply Wall St reported earlier on Geospatial Corp. (GSPH), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Geospatial Corp. is a leading innovator of asset management/analytics/mapping software and 3D mapping technologies. The Company utilizes integrated technologies to establish the accurate location and position of underground pipelines, conduits, and also other underground infrastructure data. This allows Geospatial to create accurate three-dimensional (3D) digital maps and models of underground infrastructure. Geospatial is headquartered in Sarver, Pennsylvania.
The Company has new Quality Assurance (QA) and Installed Locational Integrity Management (ILIM) programs for underground pipelines. Geospatial provides complete QA programs and ILIM programs for underground pipelines and conduits installed through Horizontal Directional Drilling (HDD) methods irrespective of depth, material, or soil conditions. The service addresses the need for accurate 3D mapping of critical pipeline segments, which exceeds regulatory requirements and supports integrity and reliability demands.
The Company provides integrated data acquisition technologies. These technologies accurately locate and map underground and aboveground infrastructure assets. This includes pipelines and surface features via Geospatial’s GeoUnderground Cloud-Based Portal. The design of GeoUnderground is around the Google Maps API.
GeoUnderground is the Company’s cloud-based Geographic Information System (GIS) platform. It provides clients with a total solution to their underground and aboveground asset management needs. Geospatial uses a collection of data acquisition tools. The Company cost-effectively maps most pipelines to an accuracy of less than 10 cm (3.9 inches).
GeoUnderground is a strong Cloud-Based GIS database. The database enables users to view and use this 3D pipeline mapping information securely from any desktop or mobile device. Geospatial is integrating Blockchain technology with GeoUnderground. This will provide a cloud-based locational software platform permitting energy companies a secure way to manage contracts, assure provenance, and track asset maintenance.
Last week, Geospatial announced that Kerr Engineered Sales and Geospatial entered into a sales and marketing agreement to provide underground mapping solutions, data acquisition and software solutions across the North East and Mid-Atlantic regions. Kerr Engineered Sales has been selling integrated solutions to major oil and gas transmission and distribution companies for decades. It has established a strong reputation representing many of the best technologies within the energy industry.
Geospatial Corp. (GSPH), closed Wednesday's trading session at $0.012, up 27.6596%, on 10,500 volume with 2 trades. The average volume for the last 3 months is 20,564 and the stock's 52-week low/high is $0.0062/$0.026.
Real Goods Solar, Inc. (RGSE)
Stock Twits, Investor Place, YCharts, Dividend Investor, Stockhouse, Morningstar, MarketWatch, InvestorsHub, Street Insider, Stock News Gazette, 4-Traders, Barchart, and TradingView reported earlier on Real Goods Solar, Inc. (RGSE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Real Goods Solar, Inc.’s RGS Energy (America’s Original Solar Company®) operates in the U.S. as a residential and small business commercial solar energy engineering, procurement, and construction company. The Company has installed over 25,000 solar energy systems for homes, businesses, schools, government facilities, and utilities across the nation. This has totaled greater than 260 megawatts of clean energy. Real Goods Solar (RGS Energy) is based in Denver, Colorado. RGS Energy is the Company’s registered trade name.
In addition, the Company is also the exclusive manufacturer of POWERHOUSE™ - an inventive in-roof solar shingle using technology developed by The Dow Chemical Company. RGS Energy entered into an exclusive domestic and worldwide license agreement with The Dow Chemical Company for the POWERHOUSE™ solar shingles system. RGS will lead all commercial activities for the product.
RGS Energy’s Solar Division consists of its Residential and Sunetric business segments. The Corporate segment includes administrative costs associated with administrative services, legal settlements, legal, information systems, and accounting and finance. POWERHOUSE™ is the Company’s business segment.
RGS Energy has its Solar 365™. This is a mobile software and online dashboard suite. With Solar 365™, users can access information and documents regarding their planned solar installation wherever and whenever it is convenient. After installation, customers can easily access and view their cost savings and production stats in kilowatts and dollars earned if net metering.
RGS Energy has its RGS POWERHOUSE™ 3.0 Solar Shingle. This is an innovative and visually appealing solar shingle system utilizing technology developed by The Dow Chemical Company.
Yesterday, RGS Energy announced it accepted its first customer purchase order for POWERHOUSE™. Mr. Dennis Lacey, Chief Executive Officer of RGS Energy, said, “We have now successfully manufactured our product as planned and accepted our first customer purchase order. We remain on track for revenue to increase substantially in the first quarter of the new year. We have already arranged with our supply chain partners for over 5 megawatts of POWERHOUSE™ to be manufactured and ready for distribution during the first quarter. We plan to increase the number of POWERHOUSE™ shingles manufactured each quarter throughout 2019.”
Real Goods Solar, Inc. (RGSE), closed Wednesday's trading session at $0.1939, up 25.6399%, on 1,122,720 volume with 224 trades. The average volume for the last 3 months is 1,747,589 and the stock's 52-week low/high is $0.064000003/$0.884000003.
First Foods Group, Inc. (FIFG)
Stockwolf, Stockwatch, Wall-St, OTC Markets, Real Investment Advice, Investors Hangout, The Street, Market Screener, TradingView, Stockhouse, Penny Stock Hub, Euro Investor, YCharts, and MarketWatch reported on First Foods Group, Inc. (FIFG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
First Foods Group, Inc. has growing interests in the food and food service industry. The Company provides management services and financing options for new foodservice brands and menu concepts. Moreover, it is growing its new concepts through proprietary development and through mergers, acquisitions, and licensing arrangements. The Company formerly went by the name Litera Group, Inc. It changed its name to First Foods Group, Inc. in February 2017. First Foods Group has its head office in Las Vegas, Nevada.
First Foods Funding invests in short-term merchant cash advances that have been producing immediate high rates of return on capital. This Division continues to realize fast growth through the reinvestment of its profits while attracting substantial new funds from outside investors.
First Foods earlier signed cannabis business expert Mr. Robert Hunt, Esq. to identify opportunities in the legal cannabis industry where the Company’s management, expertise, and relationships could have considerable effect. Mr. Hunt is one of the distinguished consultants in the legalized marijuana industry. He has been instrumental in many of the best known and most successful cannabis businesses in operation today.
First Foods Group entered into a binding term sheet in April 2017 with globally renowned chocolatier and entrepreneur Mr. Oded Brenner. This is to fully develop Mr. Brenner’s new chocolate-based retail concept. The venture is jointly owned by First Foods Group and Mr. Brenner. Initial plans are to launch two flagship stores in New York, New York, and to immediately take advantage of numerous multi-unit global franchising opportunities.
Holy Cacao is marketing premium chocolate products created and packaged by Holy Cacao consultant, Mr. Oded Brenner, founder of "Max Brenner, Chocolate by the Bald Man," for the legal cannabis sector. Mr. Brenner has incorporated an exotic mix of champagnes, sherries, and select cannabis strains into his chocolate formulas.
First Foods Group registered its Holy Cacao® subsidiary with the State of Nevada on August 31, 2017. The Company stated that Holy Cacao will soon be licensed as a THC product in the legal marijuana states.
First Foods Group recently reported GAAP Revenue of $85,510 for the second fiscal quarter of 2018. This represents an increase of 42 percent over the GAAP Revenue of $60,295 reported for the first fiscal quarter of 2018. The Company’s financial results are supporting the expansion of its Holy Cacao subsidiary. This subsidiary is finalizing negotiations to produce high-end chocolate, which will be sold and distributed to the edibles market using First Foods’ trademarked brand and packaging.
First Foods Group, Inc. (FIFG), closed Wednesday's trading session at $0.475, up 27.2605%, on 37,177 volume with 14 trades. The average volume for the last 3 months is 9,417 and the stock's 52-week low/high is $0.050999999/$0.479999989.
Zenosense, Inc. (ZENO)
Tip.us, OTC Markets Group, StreetAuthority Financial, Investors Alley, Greenbackers, SmallCapNetwork, MicroCap Gems, Investor Spec Sheet, Wall Street Daily, PennyStocks24, Insider Wealth Alert, The Trading Report, TopStockAnalysts, ProfitableTrading, Pumps and Dumps, DSR News, Wyatt Investment Research, YOLOTraderAlerts, MyBestStockAlerts, PremiereStockAlerts, Dividend Opportunities, and Trade of the Week reported previously on Zenosense, Inc. (ZENO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Zenosense, Inc. is a healthcare technology company headquartered in Valencia, Spain. Its MIDS Medical Ltd. is based in Daresbury, United Kingdom (UK). Zenosense participates in the development of transformational medical diagnostic technologies. These are hand-held devices used at the Point of Care (POC) replacing slow and costly laboratory testing. The Company’s main emphasis, via its joint venture (JV) in MIDS Medical, is the development and commercialization of MIDS Cardiac™. Zenosense lists on the OTC Markets’ OTCQB.
The Company primarily focuses on the development and commercialization of MIDS Cardiac™. This is a POC handheld device for the early detection of certain cardiac event biomarkers to considerably speed up the triage, diagnosis, treatment, and disposition of patients reporting chest pain and with suspected acute myocardial infarction (heart attack). MIDS Cardiac™ is undergoing development for use at the POC for the fast testing of cardiac markers delivering results equal or superior to laboratory gold standard accuracy within minutes.
The MIDS patented technology utilizes a tailored optical sensor like other devices. In addition, it utilzes miniaturized, highly sensitive custom built “Hall Effect” magnetic sensors embedded within a test strip as a Lab-On-Chip device. MIDS has strong patent protection. The MIDS technology platform (under license) is protected by patent applications. The intention of MIDS Cardiac™ is to perform high sensitivity troponin assays at the POC, utilizing a Magnetic Immunoassay Detection System (MIDS technology), an intellectual property (IP) used under license and undergoing further development by MIDS Medical.
Recently, Zenosense announced that its MIDS Medical Ltd. JV (MML) entered a staged funding for the next phase of development of MIDS Cardiac. On August 31, 2018, MML entered into an agreement with a third party investor for financing of up to a total amount of $1,200,000. The expectation is that this funding will cover the costs of the next important development phase of the MIDS Cardiac microfluidic test strip that aims to embody a high sensitivity (HS) troponin assay or an alike assay to prove the MIDS system on a live test.
With this Agreement, MML will receive an initial total amount of $300,000 in exchange for ordinary shares in MML, representing a 2.91 percent equity ownership, with the option to make scheduled payments up to an additional $900,000. The full $1,200,000 investment would equate to a final 10.31 percent equity ownership in MML.
At the beginning of October, Zenosense announced that its MIDS Medical Ltd. JV, MML, expanded its technical team to support the next phase of development of MIDS Cardiac. Following its recent funding agreement, MML arranged the services of three important contractors for its next phase of MIDS development. The design of these contracting arrangements is to efficiently obtain services as and when required by MML.
Zenosense, Inc. (ZENO), closed Wednesday's trading session at $0.04245, up 45.8763%, on 9,600 volume with 9 trades. The average volume for the last 3 months is 29,557 and the stock's 52-week low/high is $0.0281/$0.409999996.
Grow Solutions Holdings, Inc. (GRSO)
OTCtipReporter, StockRockandRoll, ResearchOTC, Elite Stock Alerts, Journal Transcript, Profitable Trader Authority, Stockgoodies, PennyStockScholar, and PennyStockLocks.com reported earlier on Grow Solutions Holdings, Inc. (GRSO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Grow Solutions Holdings, Inc. provides total support services in the broad area of high-yield indoor agriculture. The Company specializes in, but is not limited to, the legal and regulated growing and processing of cannabis. Its mission is to be recognized as the world’s foremost authority in the indoor high-yield agriculture industry. Formed in 2014, Grow Solutions Holding’s is based in Denver, Colorado.
Fundamentally, Grow Solutions centers on the development/distribution of high-demand products and services for cultivation, processing, as well as consumption of cannabis. Its diversified platform of operations and services for the industry consists of its Growth Technologies division (products needed to grow cannabis in and outside), its Consumer Technologies division (products to process, store and consume cannabis), and its Digital Properties division (online properties, including a state-of-the-art employment platform).
Grow Solutions Holdings acquired (in May of 2015) Boulder, Colorado-based One Love Garden Supply. One Love is a full-service garden and grow store that Grow Solutions expanded to greater than 7,000 square feet of space.
Additionally, in September of 2015, Grow Solutions acquired HyGrow. This acquisition is to expand its gardening supplies and agricultural products business. This acquisition enabled the Company to expand into Denver and Pueblo, Colorado.
Grow Solutions has developed and launched FutureTech Products of Pompano, Florida. FutureTech develops products for the consumer market to sell in smoke shops, head shops, and dispensaries.
Grow Solutions also acquired Keys Organic and Hydroponic Supply (Keys) in Florida. This acquisition of Keys expands on Grow Solutions’ existing operations in the southeast via its Future Tech division through providing a strategic location for the entry of its One Love Garden Supply subsidiary into east coast markets.
Furthermore, Grow Solutions acquired Mile High Hydro. This is a full service online grow store. It offers an extensive line of gardening supply and agricultural products to growers throughout the nation. Grow Solutions also acquired West Coast Organic and Hydroponic Supply (WCO) in Boring, Oregon.
Grow Solutions’ retail sales division uses Company funds for the acquisition of retail stores. These are stores that have shown significant presence in strategic locations.
Concerning the Company’s distribution division, it will allocate Company funds towards the manufacturing of proprietary products, bulk purchasing of a variety of products and technologies, warehousing, and the distribution and wholesale of these products to Grow Solutions retailers serving the indoor high-yield agriculture industry.
Grow Solutions’ Services division comprises Management and Consulting, Financing, Licensing, and Real Estate. Pertaining to Real Estate, the Company will acquire real estate and master leases then lease the properties to professional growers in different aspects of the indoor high-yield agriculture industry.
Grow Solutions Holdings, Inc. (GRSO), closed Wednesday's trading session at $0.0163, up 77.1739%, on 52,205,982 volume with 1,575 trades. The average volume for the last 3 months is 835,116 and the stock's 52-week low/high is $0.002499999/$0.041499998.
The QualityStocks Company Corner
- Trxade Group Inc. (TRXD)
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)
- Spectrum Global Solutions, Inc. (SGSI)
- City View Green Holdings Inc. (CSE: CVGR)
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT)
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)
- Genprex Inc. (NASDAQ: GNPX)
- Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G)
- Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P)
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF)
- Sugarmade, Inc. (SGMD)
- Marijuana Company of America Inc. (MCOA)
- Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF)
- Consorteum Holdings, Inc. (CSRH)
Trxade Group Inc. (TRXD)
Florida-based Trxade Group Inc. (OTCQB: TRXD), a pharmaceutical services network that brings the buyers and sellers of pharmaceutical products and services together in its own community of trust, technology and transparency, reported ongoing record revenue growth as well as an increase in gross profits and independent pharmacy subscribers as part of its second-quarter financial statement.
Trxade Group Inc. (TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.
Trxade will leverage and scale its fully integrated model to execute the following growth strategies:
- Increase share of pharmacist drug purchasing
- Additional SKUs and expand product breath
- Partner with Specialty and International Mfg.
- Expand mail order licenses to all 50 states
- Scale Delivmeds for consumer delivery nationwide
- Integration with telemedicine
- M&A Opportunities within drug value chain
Founded in 2010 and headquartered in Tampa, Florida, Trxade's overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company's pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.
The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.
Trxade targets these independent pharmacies, leveraging a robust, "E-Bay/Kayak-like" technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.
Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!
Trxade also targets the "consumer side" of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.
The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called "Delivmeds" (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.
Trxade's Managed Services Organization ("TrxadeMSO") enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.
These offerings ensure the best-suited pharmacy receives the patient's information, thereby ensuring appropriate medication coverage based on the patient's location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.
Health Care Market
The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.
Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.
Trxade's fair online market platform targets the nation's retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.
TRxADE's programs include:
- TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.
- RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks ("PAC") to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry.
- Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE's advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process.
Trxade's management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.
Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary
Suren Ajjarapu has served as Trxade's chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.
Prashant Patel – Director, President and Chief Operating Officer
Prashant Patel has served as Trxade's full-time president and COO, and as a director since the company's acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.
Trxade Group Inc. (TRXD), closed Wednesday's trading session at $0.70, up 7.6923%, on 1,607 volume with 4 trades. The average volume for the last 3 months is 2,478 and the stock's 52-week low/high is $0.230000004/$0.75.
- Trxade Group Inc. (TRXD) Reports Ongoing Revenue Records in Second Quarter Financial Filing
- Trxade Group Inc. (TRXD) Reports Record Revenues, Increased Gross Profit and Operating Income in Q2 2019
- Trxade Group Inc.’s (TRXD) Web Platform Protects Profit Margins, Cuts Negative Reimbursement Costs
Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)
Global developer and provider of cellular communications systems Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) today announced its receipt of a purchase order from a distributor to equip various government vehicles in Australia with the CP250 in-vehicle cellular device. To view the full press release, visit: http://nnw.fm/GcZ0J.
Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.
Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.
Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.
The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.
Siyata is headquartered in Montréal, Québec, Canada.
Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.
The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.
The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.
CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.
Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.
CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.
Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.
Siyata Mobile Inc. (SYATF), closed Wednesday's trading session at $0.36994, up 8.0133%, on 101,900 volume with 30 trades. The average volume for the last 3 months is 60,781 and the stock's 52-week low/high is $0.288599997/$0.446249991.
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) to Equip Australian Government Vehicles as Part of a Cellular Vehicle-to-Everything Pilot Program
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) to Launch UV350 with Leading National Saudi Arabian Cellular Operator
- Siyata Mobile Launches Uniden UV350 Desktop Dispatch Unit for Instant Communication to In-Vehicle and Mobile Enterprise Workforce
Spectrum Global Solutions, Inc. (SGSI)
Online video streaming services were introduced to the television-viewing market as an alternate means of watching programming that hadn’t been DVR’d, sometimes providing supplementary content as well, but streaming services have since begun to evolve into content-providing solutions with gravitas, and current global telecommunications industry plans to begin rolling out the infrastructure for a 5G network evolution have further validated a shifting business focus toward over-the-top (OTT) services as well as cable TV. Telecommunications network service provider Spectrum Global Solutions Inc. (OTCQB: SGSI) delivers network establishment and maintenance experience end-to-end, fulfilling contracts on a one-time service-needed basis as well as ongoing, multi-year contracts.
Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:
- AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
- ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
- Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.
Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.
Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.
CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.
Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.
Spectrum Global Solutions, Inc. (SGSI), closed Wednesday's trading session at $0.05, up 12.9944%, on 49,321 volume with 7 trades. The average volume for the last 3 months is 126,140 and the stock's 52-week low/high is $0.032000001/$2.5999999.
- Evolving Telecommunications Industry Providing Fertile Ground for Spectrum Global Solutions Inc. (SGSI) and its End-to-End Network Services
- Spectrum Global Solutions Inc. (SGSI) Ideally Positioned in High-Growth Market
- Spectrum Global Solutions Inc. (SGSI) Evolving with Acquisition of German Energy Infrastructure Tech Company
City View Green Holdings Inc. (CSE: CVGR)
City View Green Holdings (CSE: CVGR) on Tuesday announced the successful completion of the transfer of its option to purchase 49 Easton Road in Brantford to an arms-length financier who has now acquired the property. In exchange, CVGR and the new landlord have entered a five-year lease with a renewable term of five years. To view the full press release, visit: http://nnw.fm/wnl2P.
City View Green Holdings Inc.'s (CSE: CVGR) (formerly Icon Exploration Inc.) primary objective is to create a well-diversified company focused on assessing and potentially acquiring targets in the cannabis industry. Icon Exploration recently signed a formal share exchange agreement relating to its proposed acquisition of privately held City View Green (“CVG”), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada. CVG’s application to Health Canada for an A6ccess to Cannabis for Medical Purposes Regulations (“ACMPR”) license is now at the in-depth review stage of the licensing process.
CVG is preparing a 40,000-square-foot growing facility near Toronto to produce pharmaceutical-grade cannabis once its ACMPR license is granted. About half of the facility will initially be outfitted with state-of-the-art LED lighting, HVAC and dehumidification systems, and automation technologies to optimize the quality, safety and consistency of cannabis production. About 4,000 square feet will be devoted to an extraction laboratory featuring an ultra-efficient CO2 supercritical extraction process with plans to include ethanol extraction technology in the future.
Another 4.3 acres remains available for future construction of up to 125,000 square feet of grow and extraction space. Production plans include producing high quality edible products, distillates, and water-soluble products for the rapidly expanding CBD-infused (cannabidiol) beverage market.
Icon and CVG have assembled a talented team that includes a Master Grower with cannabis-industry experience to manage indoor grow operations and an extraction expert whose expertise in developing and launching new products was honed while working in Washington state’s cannabis sector. Having gained experience in the Washington state market the extraction expert has a number of brand ideas and recreational cannabis products that became popular in the Washington market as well as a number of in-licensing branding opportunities available to CVG. CVG has also negotiated an agreement with a private company seeking 37 retail cannabis licenses in Alberta, Canada, that provides a reciprocal exchange of shares, product, shelf space and distribution lines. Early discussions with various entities in Europe to arrange an off-take agreement for CBD oils and extracts are also underway.
The Canadian medical cannabis market has steadily been growing with an average 10 percent increase in patients each month. Now that the Canadian federal government has legalized recreational cannabis for adult users nationwide, analysts project a compound annual growth rate of nearly 78 percent from 2018 to 2021, reaching an estimated $3 billion by 2021, ArcView Market Research reports. One study from Deloitte pegged the potential economic impact of legalized medical and recreational marijuana in Canada – including transportation, licensing fees and security – at more than $22 billion over the coming years. Health Canada’s most recent data show that sales of cannabis extracts grew 961 percent in the second quarter of 2017, compared to an 89 percent increase in growth of dried cannabis during the same period.
City View Green Holdings Inc. (CSE: CVGR), closed Wednesday's trading session at $0.125, even for the day, on 49,300 volume. The average volume for the last 3 months is 119,744 and the stock's 52-week low/high is $0.094999998/$0.465000003.
- City View Green Holdings Inc. (CSE: CVGR) Closes Sale, Leaseback of Brantford Facility
- City View Green Holdings Inc. (CSE: CVGR) Strengthening Finance Strategy, Constructing Cannabis Production Facility Near Toronto
- City View Green Closes Sale and Leaseback of 49 Easton Road in Brantford, Ontario
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT)
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of popular augmented reality interactive entertainment games and toys in China, today announced the July 30, 2019 closing of its underwritten initial public offering (“IPO”). To view the full press release, visit: http://nnw.fm/l7bJM
Blue Hat Interactive Entertainment Technology (BHAT) is a cutting-edge creator, developer and operator of popular augmented reality (“AR”) interactive smart toys and educational games in China. Blue Hat’s mobile-connected entertainment platform connects physical items to mobile devices through wireless technologies, creating a unique interactive user experience in various mobile games, interactive educational materials and toys with mobile game features.
Blue Hat designs original toys and games that utilize augmented reality technology, motion capture technology, image recognition technology, voice control, light sense technology, infrared, levitation induction, and other trending scientific technologies to transverse the virtual with reality. Blue Hat creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. This combination provides users with a more natural form of human computer interaction, enhances a user’s perception of reality, and delivers a more immersive entertainment experience.
Founded in 2010, Blue Hat’s proprietary technology, product research and development, marketing channels and brand operation are the cornerstones of the business. Blue Hat focuses on the combination of “online” and “offline” activity and the interaction between “entertainment” and “product” to create a high-tech entertainment platform combining mobile games and AR. With the help of computer graphics, motion capture technology, image recognition technology and visualization technologies, Blue Hat accurately “places” virtual objects into the physical world, creating a new and stimulating visual environment for users.
Blue Hat recently displayed a variety of its sci-tech products at the Guangzhou International Toy Exhibition in China including AR Racer, Elastic Bubbles, AR Space Track, AR Alloy Toy Car, AR Need a Spanking, 5D Animated Magic Aquarium, Bug Travelers, AR Picture Book and other interactive games and smart toys.
The company has multiple products in development including new generations of four primary product lines and two new product lines.
Patents and Copyrights
Blue Hat’s advanced AR technology in interactive entertainment is protected by 178 authorized patents with 44 patents in various stages of the application process.
Another 14 applications for Patent Cooperation Treaty, or PCT, have been filed for international patents. As of March 31, 2019, the company owns 645 copyrights for artwork, 71 registered trademarks and 27 software copyrights.
Sales and Marketing
There has been rapid growth in the toys and games industry in China over the last several years. Total retail sales of toys and games in China soared from RMB 111.8 billion in 2012 to RMB 276.5 billion in 2017 with an average annual growth rate of 19.9% in 2017. Blue Hat believes the company is well positioned with little competition as the toy industry rapidly shifts toward intelligent and interactive toys and games. Retail sales of electronic toys grew at 24% annually in 2017 while that of traditional toys grew at 7%.
In addition to a powerful ecommerce presence, Blue Hat has long-term relationships with partnered distributors that place the company’s AR interactive entertainment products into well-known international retail chains and retail outlets. Blue Hat’s integrated online and offline sales channels include e-commerce giants such as Amazon and Alibaba, retail chain stores and the company’s physical experience store located in Xiamen, China. Blue Hat plans to open or franchise approximately 100 additional stores in China by 2021.
Blue Hat’s community-based platform offers users a highly engaged and interactive community with online communication forums and offline social activities. The company advocates a new model of “teaching through lively activities” and combines AR technology with education, integrating its products into situational teaching, roleplaying and man-machine interaction. This novel educational experience helps realize optimal transformation of information, creating a knowledge and enhancing cognition.
Director and CEO Xiaodong (Sean) Chen has over 20 years of experience creating, developing and producing toys and games related products. Chen earned his EMBA from Renmin University of China and has been chairman of the board of directors and general manager of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.
CFO and Director Caifan, who has over 20 years of financial accounting and taxation experience, earned a degree in finance from Hunan University of Finance and Economics. He has served as director, deputy general manager and financial controller of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.
Jianyong Cai, chief technology officer and director, has over 35 years of experience in data communication principles, communication network foundation, software engineering, communication network theory and technology and computer network architecture. He holds degrees in data communication principles, communication network foundation and software engineering from University of Science and Technology of China. He has been director, deputy general manager and chief engineer of Fujian Blue Hat Interactive Entertainment Technology Ltd. since January 2010.
Blue Hat Interactive Entertainment Technology (BHAT), closed Wednesday's trading session at $3.82, off by 3.7783%, on 438,533 volume with 1,112 trades. The average volume for the last 3 months is 729,766 and the stock's 52-week low/high is $3.65000009/$6.25.
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces IPO Closing
- Blue Hat Interactive Entertainment Technology Announces Pricing of IPO and Increases Offering Size
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) is “One to Watch”
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) was highlighted in a publication from Financialnewsmedia.com, examining the impending growth of the CBD edibles markets. Citing the recent ArcView report, saying that “legal cannabis-derived edible products, from candy and chocolate to infused beverages, is a sector worth watching over the next few years,” the report stated.
Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.
Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.
Canopy Rivers’ expanding portfolio includes:
- Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
- CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
- Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
- James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
- LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
- PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
- Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
- Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
- Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
- TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
- Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.
As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.
Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.
Canopy Rivers Inc. (CNPOF), closed Wednesday's trading session at $2.09949, off by 0.967453%, on 64,916 volume with 158 trades. The average volume for the last 3 months is 104,874 and the stock's 52-week low/high is $1.75/$7.30155992.
- Cannabis Edibles Market Projected to Quadruple in U.S. and Canada to $4.1 Billion
- Canopy Rivers' Flagship PharmHouse JV Licensed By Health Canada
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Releases Q4, Fiscal Year 2019 Financial Highlights; Provides Corporate Update
Genprex Inc. (NASDAQ: GNPX)
Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) this morning announced it has initiated the first phase of branding its lead drug candidate, Oncoprex(TM) immunogene therapy, and has completed and submitted non-proprietary drug name selections to the American Medical Association’s United States Adopted Names (“USAN”) Council. To view the full press release, visit: http://nnw.fm/1eKb3.
Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.
Research and Development
Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.
Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.
Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.
Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.
TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.
Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.
Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.
Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.
Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.
Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.
Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.
Genprex Inc. (NASDAQ: GNPX), closed Wednesday's trading session at $0.9923, off by 0.760076%, on 17,763 volume with 68 trades. The average volume for the last 3 months is 40,235 and the stock's 52-week low/high is $0.900099992/$3.38000011.
- Genprex, Inc. (NASDAQ: GNPX) Initiates First Phase of Branding Lead Drug Candidate
- Genprex Inc. (NASDAQ: GNPX) Provides Update on Lead Drug Candidate for Treatment of Non-Small Cell Lung Cancer
- NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Advances Toward Lead Drug Candidate Commercialization through Retaining Addison Whitney to Oversee Naming Process
Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)
Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) was featured today in the 420 with CNW by CannabisNewsWire. A medical marijuana patient and a registered nurse in Colorado are teaming up to start a hotline to answer the questions that potential medical marijuana users have about the drug. If all goes according to plan, this hotline will be launched in September.
Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.
To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.
This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.
Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.
Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.
Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.
Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.
President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.
Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.
Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.
Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.
Sproutly Canada, Inc. (OTCQB: SRUTF), closed Wednesday's trading session at $0.3833, off by 1.7683%, on 123,566 volume with 71 trades. The average volume for the last 3 months is 443,184 and the stock's 52-week low/high is $0.189099997/$1.875.
- 420 with CNW – Colorado Nurses to Launch Cannabis Information Hotline
- Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) Announces Q1 2020 Financial Results
- Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) Announces THR Subsidiary Cannabis Cultivation Results that Outperform Design Capacity by 50%
Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P)
The remarkable rise of the cannabis industry and its variety of sectors has created a sea change in some market metrics, drawing investors’ risk capital from last year’s newsmakers (http://nnw.fm/9zL6U). At the forefront of the trend, Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) has been plying its experience in building an expanding portfolio of cannabis investments to create high-quality cash flow opportunities in states where limited licenses are granted for professional operations.
Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P), dba Innovative Properties Inc., is a Canadian investment company pursuing interests in high-quality cash-flow assets in real property, securities, cryptocurrency and all branches of the cannabis sector. The company's focus on strategic revenue generation, EBITDA and growth is enshrined in its moto, "One team. One goal," and is reflected in its name: "Na bis," which is defined as, "repeat performance" or "encore."
While the Nabis' targets span numerous industries, the company aims to establish an Anchor Investment Portfolio primarily through the acquisition of majority interests in high quality U.S. cannabis assets and brands that have achieved cash flow. The company will then employ a hands-on approach to assist the investee in implementing standards and consistency to enhance their operations.
Criteria for investment targets are as follows:
- Positive EBITDA, vertically integrated operators in limited license states with large addressable markets
- Emphasis on operations that add material EBITDA within 12 months with enhanced access to capital and Nabis' value add approach on operations and brand consistency
- Identifying proven operators with good expertise to add value to a consolidation strategy
- Focused on MSOs (Multi-state Operators) with strong brand traction
- Pharma grade cultivation, extraction, dispensaries and other addressable operations
Nabis has completed investments in five Michigan properties with Cannabis provisioning, processing and cultivation licenses. The Company has also entered into binding Letters of Intent ("LOI") to invest in vertically integrated assets in Michigan, Arizona and Washington State. The company's goal is to be invested in four to five additional states in the coming months.
Arizona – LOI to acquire full control of Organica Patient Group Inc. ("OPG") and RDF Management Group. OPG is a fully integrated medical marijuana business licensed under the provisions of the Arizona Medical Marijuana Act. Its assets include the Chino Valley MMJ Dispensary and fully established Patient Group, which since 2012 has operated as "Organica Patient Group" in Chino Valley. OPG also operates a 26,000-square-foot indoor cultivation and processing center along with a 56,600-square-foot greenhouse in Prescott Valley; has its own branded products and wholesale operations which includes distribution to more than 25% of the dispensaries in Arizona; and has exclusive manufacturing and licensing agreements with Fire Brand, Gas Extracts and Donuts Concentrate products distributed within Arizona.
Michigan – LOIs to invest in multiple strategically located properties that have or are eligible for municipal approvals for provisioning centers in Michigan. The company is currently evaluating 10 to 15 additional municipally approved locations in Michigan that would substantially increase the company's overall presence in the U.S. cannabis space.
Washington State – LOI to purchase assets from PDT Technologies LLC, including extraction and production equipment and rights to lease the current production facility in Port Townsend, Wash. The LOI includes licensing rights to produce Chong's Choice Brand CO2 Vape Cartridges, one of the leading and most recognizable brands in the cannabis space. Expansion plans include construction of a new ISO designed extraction clean room and GMP lab facility with new, highly specialized equipment with two extraction lines. The facility could produce up to 20,500 kg of cannabis concentrate on an annual basis.
Hivemind Refinery – LOI to invest in a 70% interest of Hivemind Refinery, an established line of CBD-based wellness products in the United States. The investment into Hivemind expands Nabis' investment portfolio to CBD edibles, water, drops, lotions, and other CBD wellness products across the spectrum. Nabis anticipates Hivemind will be a premium consumer CBD line to be distributed across the U.S. and Canada and will focus on products utilizing locally grown, premium CBD along with unique formulations and delivery systems.
Bloombox – binding term sheet with Momentum Ideas Co. to acquire certain assets used and marketed under the brand "Bloombox," a leading intelligent retail cannabis software platform that includes the Bloombox Software and data platform. The acquisition of Bloombox will create a dominating presence in the U.S. cannabis market, featuring an integrated ecosystem of modern, next-generation cannabis technology. Bloombox is one of the world's first standards-based cannabis software systems, enabling frictionless integration with nearly any business system or regulatory body.
Proven Management Team
CEO and Director Shay Shnet has over 20 years of experience in business and was most recently a founding partner and vice president of operations of MPX Bioceutical (CSE: MPX). While at MPX, Shnet focused on the North American cannabis space and helped build the company's portfolio of international cannabis assets. He is highly skilled in finding unique opportunities and has been directly involved with the development, branding, importing, consumer packaging and distribution of a wide variety of product lines.
President Mark Krytiuk is a very successful cannabis operator and was a founding partner of MPX. As the vice president of grow operations of MPX, he oversaw the production of medical marijuana and pharma-grade products across North America. He has been directly involved in overseeing the rapid expansion and buildout of nine facilities in three countries with budgets ranging up to $30 million. Krytiuk's experience includes consulting and working with customers to develop individual requirements for indoor and outdoor cannabis cultivation while working with federal regulators and licensing bodies to ensure compliance.
Nabis Holdings (OTC: NABIF), closed Wednesday's trading session at $0.202, off by 2.4626%, on 66,688 volume with 25 trades. The average volume for the last 3 months is 46,265 and the stock's 52-week low/high is $0.190500006/$0.791499972.
- Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) Enters California Cannabis Market with Dispensary in Southern Desert
- Alternative Consumption Methods That Are Reshaping the Cannabis Industry - CFN Media
- Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) Acquires 49% Interest in Budding Cannabis Industry Disruptor
IONIC Brands Corp. (CSE: IONC) (OTC: IONKF)
IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) is pleased to announce that PharmaCann LLC’s (“PharmaCann”) Illinois dispensaries are exclusively launching Zoots Cannabis Infused Edibles and will be available this month, providing consistent relief for medical cannabis patients. Also today, the company was highlighted in a publication from Financialnewsmedia.com, examining how ArcView recently stated in a report that legal cannabis-derived edible products, from candy and chocolate to infused beverages, is a sector worth watching over the next few years, with edibles projected to grow from 12 percent to 14 percent of the total cannabis market by 2022, while flower drops from 50 percent to 36 percent
IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) is a national cannabis holding company building a multistate portfolio of award-winning premium and luxury brands in the cannabis space. Established in 2015, IONIC Brands has demonstrated its ability to expand and operate multiple cannabis concentrate consumer brands in leading markets across the western United States, with current operations in Washington, Oregon, California and Nevada. The company continues to strategically expand nationwide to remain a leader of the highest-value segments in the cannabis market.
With a focus on quality, responsibility and respectability, IONIC’s product lines are pioneering the changing landscape of cannabis consumption. The company’s refinement practices are a result of a passionate commitment to craft the finest, small-batch cannabis oils and cannabis concentrates in the world – without glycols, glycerins or additives.
IONIC’s Certified Clean program verifies that every product leaving the company’s facilities meets or exceeds state mandates on pesticide testing. The testing is conducted by individually testing every batch which ensures and enhances trust and transparency. IONIC recently paired its Certified Clean program with Lucid Green Inc. and its revolutionary technology platform designed to provide vital safety information. Lucid Green’s technology provides a direct-to-consumer data platform, providing instant access to a library of product specific insights by simply scanning the package’s QR code with a smartphone camera.
Elite Brand Portfolio/Acquisitions
- IONIC, the company’s flagship recreational branded product, is a stylish and sophisticated premium vape pen line that has earned customer loyalty and a reputation as a consistent Top 10 vape brand in Washington state. IONIC’s immediate product line expansion plans include THC/CBD mixes, low-dose products, high-end edibles, CASK oil and device innovation.
- WW Agriculture cultivates cannabis outdoors on a 140-acre eastern Washington State farm capable of producing up to 100,000 pounds of cannabis for less than $0.10/gram.
- ZOOTS, a Washington-based edibles company, utilizes patent-protected ultra-clean CO2 extraction hardware to create proprietary formulations of refined cannabis oils and distillates. Through MedMen dispensaries, Zoots Edibles are currently available in Washington and Colorado and will soon be on shelves at dispensaries in Massachusetts, New York and Pennsylvania.
- Vuber Technologies hardware produces the best vaporization experience on the market.
- Vegas M Stick vaporizer pens are distributed to stores in Washington State with plans to expand to Oregon and Nevada.
- Vegas Valley Growers is a revenue-generating, vertically integrated operation in Las Vegas, Nevada, with a full complement of production, manufacturing and distribution licenses.
IONIC has also acquired two U.S. patents issued to Canna Café that are related to cannabinoid (CBD) infused coffee and CBD-infused coffee in a Keurig ® K-Cup ® Pod. An international patent is in process for cannabis-infused teas.
Experienced Management Team
IONIC Brands is led by an innovative product team, powerful sales organization and a world-class marketing group.
Chairman & CEO John Gorst has built and sold four different technology companies with market valuations in excess of $600 million. Gorst has been at the forefront of IONIC’s expansion and development into Washington state’s leading vaporizer brand.
Andrew Schell, President, Vice-Chairman & Co-Founder, has built several successful companies. Schell has an engineering background rounded in operations, strategy and corporate law, and most recently was CEO of a U.S. Department of Defense company specializing in military operations.
Christian Struzan, Chief Marketing Officer & Co-Founder, has over 30 years of experience in marketing and branding in the entertainment and consumer goods industries. Struzan founded an advertising agency which developed and executed marketing campaigns for feature films such as the Star Wars franchise, Fight Club, and the television series American Idol. He has also worked on global brands such as Guinness, Stella Artois and Beck’s.
Johnny Stange, Chief Revenue Officer, was formerly a director of sales for the southern California region for Treasury Wine Estates, a major wine wholesaler, where he grew and oversaw annual sales of $250 million. Stange is leading the charge in IONIC’s aggressive sales growth plans across multiple states.
In 2018, IONIC was voted one of the “Top 50 Companies to Work for in Cannabis” by MG Magazine, a publication serving cannabis industry professionals.
IONIC Brands Corp. (OTC: IONKF), closed Wednesday's trading session at $0.1346, off by 3.0329%, on 187,787 volume with 96 trades. The stock's 52-week low/high is $0.035999998/$0.634559988.
- IONIC BRANDS Announces Its Zoots Premium Cannabis Infused Edibles Launch in Pharmacann’s Illinois Dispensaries
- Cannabis Edibles Market Projected to Quadruple in U.S. and Canada to $4.1 Billion
- Ionic Brands Completes Acquisition of Zoots - Premium Cannabis-Infused Edibles and Infused Products
Sugarmade, Inc. (SGMD)
Sugarmade Inc. (OTC:SGMD) today announces its placement in an editorial published by CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company for private and public entities in the cannabis industry. To view the full publication, titled “Political Backing, Investor Interest Fuel Kentucky Hemp Boom,” please visit: http://cnw.fm/VD1Cz. Also today, the company was featured in the 420 with CNW by CannabisNewsWire.
Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.
Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.
Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.
Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.
Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.
Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.
Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.
CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.
Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.
Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6
Sugarmade, Inc. (SGMD), closed Wednesday's trading session at $0.01175, off by 8.9147%, on 5,183,619 volume with 99 trades. The average volume for the last 3 months is 3,171,693 and the stock's 52-week low/high is $0.010099999/$0.197500005.
- Sugarmade Inc. Featured in CannabisNewsWire Publication Discussing Soaring Interest in Kentucky’s Hemp Boom
- 420 with CNW – Colorado Nurses to Launch Cannabis Information Hotline
- Sugarmade Announces Initial Investment in Hempistry and Completion of BZRTH Audit
Marijuana Company of America Inc. (MCOA)
Marijuana Company of America Inc. (MCOA) today provided an update to its previously disclosed reverse stock split. As stated in its press release dated July 3, 2019, and corresponding Form 8-K filed with the Commission, the Company originally anticipated the effective date of the 1-for-60 reverse stock split to occur on July 31, 2019.
Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.
The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.
The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.
The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.
Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.
Marijuana Company of America Inc. (MCOA), closed Wednesday's trading session at $0.006, off by 3.2258%, on 14,033,659 volume with 255 trades. The average volume for the last 3 months is 8,538,604 and the stock's 52-week low/high is $0.0057/$0.039299998.
- Marijuana Company of America Issues Update on Proposed Reverse Stock Split
- Marijuana Company of America Inc. (MCOA) Expands Portfolio of Legal Cannabis, Industrial Hemp Investments
- Marijuana Company of America Inc. (MCOA) Continues to Build Steam in California’s Cannabis Marketplace
Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF)
Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) is a medical device technology provider focused on addressing dermatological needs in the multi-billion-dollar cosmeceutical industry. The company’s effective, non-invasive and pain-free skin care is based on proprietary technology which has received Class II medical device status from the U.S. Food and Drug Administration.
Therma Bright’s portfolio includes products, devices and treatments that have both cosmetic and medicinal or therapeutic benefits, such as for relief of pain, itch and inflammation resulting from more than 20,000 types of insect and marine life bites and stings, including bees, wasps, hornets, mosquitos, black flies and jellyfish.
The Company’s current focus is to market its products online through various social media networks, and to eventually re-establish relationships with major North American and Global retailers.
The company currently has two products on the market and another in the research and development phase:
InterceptCS™ is a thermal therapy device for the treatment and prevention of cold sores caused by the herpes simplex Type 1 virus*. Symptoms typically include sores around the mouth and lips which InterceptCS™ treats by application of controlled topical heat with no risk of burning the skin. When used at the first sign of an oncoming cold sore application of InterceptCS™ can prevent symptoms from developing. Infrared energy and light from the device penetrate the skin killing cells infected with the virus.
InterceptCS™ is available without prescription and comprises a battery powered ergonomic hand-held unit and a disposable single-use treatment activator. Therma Bright has completed prototyping of multi-use activators for InterceptCS™. The company plans to bring to market 5, 10 or 20 multi-use activations at prices that will offer customers greater value than the current single-use activator.
The other Therma Bright product currently under development is TherOZap™, a next generation thermal therapy device powered by the company’s core technology, which is approved by the FDA as a Class II medical device for the relief of the symptoms of insect bites. Therma Bright is testing a new easier-to-use prototype of the device for effectiveness against Zika virus and other diseases carried by mosquitos. Once the technology proves effective, Therma Bright intends to seek regulatory approvals and extend the prototype enhancements to a new commercial version of TherOZap™.
Therma Bright is also conducting research and development on a unique thermal therapy device that would incorporate medical grade cannabis or cannabidiol (“CDB”) sourced from hemp as a cream or gel to provide relief of back, knee and other joint pain. In preparation, the company has incorporated a wholly owned subsidiary to hold any technology for use or application of cannabis. Once approvals are secured, the company plans to sell the device through licensed cannabis producers or retailers across Canada and in international markets where use of cannabis has been legalized. The company has initiated trademark and patent protection for its thermal therapy technology incorporating medical cannabis. Therma Bright has indicated it will seek an acquisition to help further development of this product.
A report by market intelligence firm Mordor Intelligence put the global cosmeceuticals market at a value of nearly US$47 billion in 2017 and projects it to be worth more than $80 billion by 2023, growing at a rate of almost 9.5 percent annually. Medical research estimates that somewhere between 20 percent and 40 percent of the population suffer occasional cold sore outbreaks. In Canada those figures would mean five to 10 million people, and in the U.S. some 40 million to 80 million, with recurring cold sores, representing a substantial potential market for Therma Bright.
Rob Fia serves as Therma Bright chairman and CEO. Fia has extensive contacts in the investment community and the financial sector as well as knowledge of various Canadian stock exchange listing processes and requirements. His 18 years in the investment business has included equity research and advising promising early stage companies on corporate finance. Therma Bright CFO Victor Hugo is a senior financial analyst at Marrelli Support Services Inc., for which he provides CFO, accounting, regulatory compliance, and management advisory services to companies listed on the TSX, TSX Venture Exchange and other Canadian and US exchanges.
**Based on double blind placebo study, the InterceptCS™ is approved by Health Canada for the claim “For prevention of cold sores when used within 3 hours of the onset of the prodrome.” The InterceptCS™ is not approved by the United States FDA or any claim of clinical indication, clinical efficacy, and/or cure or prevention of disease.
Therma Bright, Inc. (OTC: THRBF), closed Wednesday's trading session at $0.022, even for the day, on 250 volume. The average volume for the last 3 months is 3 and the stock's 52-week low/high is $0.009899999/$0.028999999.
- Therma Bright Inc. Continues Testing of TherOZap(TM) Technology Against the Zika Virus
- 420 with CNW – How Marijuana Legalization Law in Illinois Differs from All Others
- 420 with CNW – Missouri Puts Final Touches to Medical Marijuana Rules
Consorteum Holdings, Inc. (CSRH)
Consorteum Holdings, Inc. (CSRH) is a software development and mobile solutions company focused on the delivery of digital offerings to mobile devices. The company provides mobile offerings, delivery of mobile content, mobile payments solutions and products through a mix of direct offerings, partnerships, license agreements and joint venture arrangements. A multi-year transition from a transaction management company focused on transaction processing solutions and products for the payment processing and financial transaction markets to multiple business verticals deepens the company’s commitment to deliver innovating solutions to end users who are using smart handset devices in radical new ways.
Consorteum Holdings, utilizing its Universal Mobile Interface™ (“UMI”) solution, offers opportunities in numerous markets with its capacity to support fully regulated, regionally compliant financial and social transactions via web and mobile. The company’s UMI technology has the capacity to provide solutions in FinTech, data analytics, secure payment processing, compliance lead transaction management and various digital social event sectors. The UMI platform allows cross operating system development to support all mobile devices while addressing the complex and highly regulated needs of the mobile FinTech industry.
Led by the development team at Consorteum’s wholly owned subsidiary 359 Mobile Inc., the Company has created an end-to-end FinTech solution utilizing the company’s UMI technology platform. Current mobile application and transaction solutions are plagued by poor experiences. Because UMI’s technology platform is designed to work across innovative payment, experience and product solutions, 359 Mobile believes there are both direct and partnership opportunities for the 359 Mobile UMI solution.
Consorteum’s primary sales and marketing strategy is focused on enabling and delivering solutions to the global mobile FinTech market with an emphasis initially on mobile gaming. The trend towards increased mobile gambling supports the need for a mobile platform such as the UMI to meet existing and new compliance regulations for the online gambling industry. The online gambling market is projected to double to nearly $1 trillion by 2021, according to a study by Juniper Research, with the majority of growth in this sector attributed to mobile devices. Consorteum’s management team believes there are fresh opportunities in this sector such as Mobile Marketing Services providing one-to-one marketing experiences for consumers; offering real-time services to Mobile Sports Book operators; and providing fixed odds betting solutions as well as social-based transactional solutions.
Consorteum’s management team includes Chairman and CEO Craig A. Fielding, a co-founder of the company with extensive experience in technology, programming and large system building; and Chief Operating Officer Patrick Shuster, who has over 25 years of business experience in sales, engineering, operations and marketing for the telecommunications industry. They are joined by John Osborne, SVP of Technology of ThreeFiftyNine Inc., an innovator in embedded systems hardware and software design; Patrick Doran, SVP of business development and marketing with over 30 years of diversified experience in major corporations as well as early stage companies; and Glenn Charlesworth, VP of Accounting, a seasoned executive with a solid track record in financial reporting, strategic planning, general management and operations, finance, start-up situations, and cash flow challenged operations.
Consorteum Holdings is committed to bridging the mobile divide by providing mobile connectivity, secure transactional processing and social connectivity solutions for both cloud and hosted based offerings in multiple business sectors.
Consorteum Holdings, Inc. (CSRH), closed Wednesday's trading session at $0.0005, even for the day, on 2,000 volume with 1 trade. The average volume for the last 3 months is 140,784 and the stock's 52-week low/high is $0.0005/$0.002199999.
- NetworkNewsBreaks – Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Connects in a Post-PC World
- NetworkNewsBreaks – Consorteum Holdings, Inc. (CSRH) Providing Data Stream Integration to Several Vertical Markets
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces Pricing of IPO and Increases Offering Size
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) 420 with CNW – Senate Could Hold Hearings on Cannabis Banking Later this Month
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Flagship PharmHouse JV Licensed By Health Canada
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) 420 with CNW – NYC Council Passes Two Cannabis Reform Resolutions
- ChineseInvestors.com (CIIX) Investor Webinar Replay Now Available
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green Holdings Inc. (CSE: CVGR) Strengthening Finance Strategy, Constructing Cannabis Production Facility Near Toronto
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Cool Events Inc. (RNWR) Reports Strong Attendance at Signature Fun Runs
- Earth Science Tech, Inc. (ETST) Attributes Increases in Distribution, Demand for Upsurge in Revenues
- Endonovo Therapeutics (OTCQB: ENDV) SofPulse Safely Reduces Pain, Swelling
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) QuadSight(TM) Prototype Ordered by American Subsidiary of Leading Global Supplier
- Genprex Inc. (NASDAQ: GNPX) Provides Update on Lead Drug Candidate for Treatment of Non-Small Cell Lung Cancer
- Geyser Brands Inc. (TSX.V: GYSR) Releases Post-RTO Financial Results for the 8-months ended March 31, 2019
- Golden Developing Solutions, Inc. (DVLP) Building Robust Portfolio of CBD Businesses
- Grapefruit Boulevard Investments Inc. (IGNG) Announces Filing of Registration Statement
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Posts Updated Terms to Spring Oaks Acquisition
- Green Hygienics Holdings Inc. (GRYN) 420 with CNW – Cannabis Flavonoids Could Trigger Another Medical Marijuana Revolution
- Hemptown USA - Advances Growth Strategy via Nutraceutical Manufacturing Facility Acquisition
- INmune Bio, Inc. (NASDAQ: INMB) Strategy in Fighting Cancer with Body’s Own Natural Cells
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) Completes Acquisition of Zoots - Premium Cannabis-Infused Edibles and Infused Products
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) Summarizes DehydraTECH(TM) Technology Licensees
- Marijuana Company of America Inc. (MCOA) Expands Portfolio of Legal Cannabis, Industrial Hemp Investments
- MustGrow Biologics Corp (CSE: MGRO) Recent CSE Listing Generates New Opportunities
- Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P) Alternative Consumption Methods That Are Reshaping the Cannabis Industry - CFN Media
- Nightfood, Inc. (OTCQB: NGTF) Live OTCQB Venture Company Investor Conference August 1st
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Five of the Top Hemp Stocks to Watch in 2019
- ORHub Inc. (ORHB) Settles Litigation with Former Chief Financial Officer
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) President Issues Letter to Shareholders
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Achieves Key Milestone of Form 10 Registration Statement Effectiveness
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Debuts New Look for Cannabis Line
- Pressure BioSciences Inc. (PBIO) Entry into CBD Market Aims Next-Gen Nanoemulsification Platform at Critical Water-Solubility Issues
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Holds Favorable Position as Rising EV Market Boosts Lithium Demand Worldwide
- Sharing Services Global Corporation (SHRG) Capitalizing on New Direct-Selling Opportunities Driven by Changing Retail Industry
- SinglePoint, Inc. (SING) Shareholder Update Overviewing Key Growth Initiatives: Solar, Hemp, and Merchant Services
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) to Launch UV350 with Leading National Saudi Arabian Cellular Operator
- Spectrum Global Solutions, Inc. (SGSI) Evolving with Acquisition of German Energy Infrastructure Tech Company
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Announces Q1 2020 Financial Results
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Breaks Ground for Its Direct Lithium Extraction Demonstration Plant
- Sugarmade, Inc. (SGMD) Political Backing, Investor Interest Fuel Kentucky Hemp Boom
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) and Khalifa Kush Enterprises Canada Launch Premium Cannabis Oil
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Global CBD Sales Expected to Grow to $22 billion by 2022
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Continues Testing of TherOZap(TM) Technology Against the Zika Virus
- TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) 420 with CNW – Thousands Submit Comments Urging FDA to Allow CBD in Supplements and Foods
- Trxade Group Inc. (TRXD) Reports Record Revenues, Increased Gross Profit and Operating Income in Q2 2019
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Commences CO2 Extraction Operations at Napanee Facility
- VPR Brands, LP (VPRB) Adds HRB Turbo Dry Herb Vaporizer to Extensive Product Suite
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) 420 with CNW – Study Looks at How Marijuana Extracts Can Kill Cancer Cells
- Willow Biosciences Inc. (CSE: WLLW) Investor Ideas Potcasts, Cannabis News and Stocks on the Move: Special Interview with Trevor Peters of Willow Biosciences
- Youngevity International, Inc. (NASDAQ: YGYI) 420 with CNW – Michigan Caregivers Grow More than a Million Marijuana Plants
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.